Toward Standardized Methodologies for Drug-Induced Proarrhythmia Classification: An In Silico Proof of Concept
Abstract
Background: The Comprehensive in vitro Proarrhythmia Assay integrates experimental electrophysiology with in silico simulations to improve the prediction of drug-induced proarrhythmic risk and to address regulatory limitations associated with traditional QT interval-based safety assessment. In recent years, increasing attention has been directed toward the arrhythmogenic potential of drugs, leading to the development of multiple computational frameworks. However, substantial methodological variability still exists across studies, including differences in electrophysiological models, biomarker selection, and population sampling strategies. Using a model of electrotonically coupled ventricular cardiomyocytes, this study proposes a proof of concept for a standardized in silico framework aimed at predicting drug-induced arrhythmic risk. Methods: A virtual population of ventricular cellular models was generated and calibrated using patient-derived electrophysiological data. Ten drugs representing 3 levels of proarrhythmic risk were evaluated both in isolated-cell simulations and in electrotonically coupled cellular networks. Drug classification was performed using a novel arrhythmic risk score, which integrates 8 established electrophysiological biomarkers. The analysis also evaluated the effects of electrotonic coupling, biomarker reduction, and cellular subsampling on the stability of the risk estimation. Results: The electrotonically coupled cell model reproduced the…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.